Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 24
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03609359 | Lenvatinib and Pembrolizumab Simultaneous Combination Study | ||
| NCT03480373 | Electronic Cigarette Use During Pregnancy | ||
| NCT04465968 | Efficacy and Safety of CRT, Durvalumab and Surgery for SST | ||
| NCT02851004 | Special Combination of BBI608 and Pembrolizumab | ||
| NCT07100704 | Recurrent/Metastatic Olfactory Neuroblastoma: Evaluating the Efficacy and Safety of Nivolumab | ||
| NCT04740372 | Development of an International COVID-19 Specific Quality of Life Questionnaire, Phase III. The OSLO COVID-19 QLQ | ||
| NCT02410369 | Study of S-588410 After Adjuvant Chemotherapy for Completely Resected Non-small- Cell Lung Cancer | ||
| NCT04879368 | RegoNivo vs Standard of Care Chemotherapy in AGOC | ||
| NCT05034887 | Phase 2 Study of Trastuzumab Deruxtecan in the Neoadjuvant Treatment, or Trastuzumab Deruxtecan Plus Capecitabine Plus Durvalumab(MEDI4736) in the Preoperative and Postoperative Adjuvant Treatment for Patients with HER2 Positive Gastric and Gastroesophageal Junction Adenocarcinoma | ||
| NCT05696548 | Nivolumab Plus Lenvatinib Against Anaplastic Thyroid Cancer (NAVIGATION) | ||
| NCT02948348 | Study to Nivolumab Following Preoperative Chemoradiotherapy | ||
| NCT04040361 | Neoadjuvant Therapy of Pembrolizumab + Ramucirumab for PD-L1 Positive Stage IB-IIIA Lung Cancer (EAST ENERGY) | ||
| NCT04417192 | Olaparib Monotherapy and Olaparib + Pembrolizumab Combination Therapy for Ovarian Cancer | ||
| NCT03000751 | CT DOSE Collaboratory | ||
| NCT05394740 | Clinical Study of Regorafenib and Nivolumab Plus Chemotherapy | ||
| NCT06043921 | Multicenter Study of Circulating Tumor DNA in Patients With Pancreatic Cancer Using a Personalized Panel | ||
| NCT07018570 | An Open Label Phase 2 Study of Total Neoadjuvant Therapy (TNT) Consisting of FLOT With Pembrolizumab and Short Radiation for Patients With Locally Advanced Gastroesophageal Junction Adenocarcinoma | ||
| NCT05694819 | Darolutamide in Patients With Androgen Receptor-Positive Salivary Gland Carcinoma (DISCOVARY) | ||
| NCT03172819 | Special Combination of OBP-301 and Pembrolizumab | ||
| NCT04457297 | Initial Attack on Latent Metastasis Using TAS-102 for ct DNA Identified Colorectal Cancer Patients After Curative Resection | ||
| NCT04288999 | Surgery Plus Chemo Versus Chemoradiotherapy Followed by Surgery Plus Chemo for Locally Recurrent Rectal Cancer | ||
| NCT04745988 | An Open Label Phase 2 Study to Evaluate the Safety and Efficacy of Lenvatinib with Pembrolizumab or Lenvatinib, Pembrolizumab and FLOT in the Neoadjuvant / Adjuvant Treatment for Patients with Gastric Cancer | ||
| NCT05646511 | TNT of SCRT+CAPOX vs SCRT+CAPOXIRI for Locally Advanced Rectal Cancer | ||
| NCT03406871 | Regorafenib and Nivolumab Simultaneous Combination Therapy |
